Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Nutex Health Inc. (NUTX) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$243.99M
Net Income	$-17.70M
Cost of Goods Sold	$119.06M
Gross Profit	$124.92M
Operating Expenses	$210.31M
Operating Income	$33.68M
Non-Operating Income/Expense	$-9.95M
Pre-Tax Income	$23.73M
Normalized Pre-Tax Income	$23.73M
Income after Taxes	$16.14M
Income from Continuous Operations	$16.14M
Consolidated Net Income/Loss	$16.14M
Normalized Income after Taxes	$16.14M
EBIT	$33.68M
EBITDA	$38.93M
Weighted-Average Shares Outstanding (Basic)	5.99M
Weighted-Average Shares Outstanding (Diluted)	5.99M
Earnings per Share (EPS) (Basic)	$-2.95
Earnings per Share (EPS) (Diluted)	$-2.95
Balance Sheet Financials
Current Assets	$473.02M
Property, Plant, and Equipment	$82.92M
Long-Term Assets	$368.00M
Total Assets	$841.03M
Current Liabilities	$194.87M
Long-Term Debt	$278.47M
Long-Term Liabilities	$309.28M
Total Liabilities	$504.15M
Common Equity	$336.88M
Tangible Shareholders Equity	$308.08M
Shareholders Equity	$336.88M
Common Shares Outstanding	6.59M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$78.22M
Cash Flow from Investing Activities	$0.13M
Cash Flow from Financial Activities	$-22.26M
Beginning Cash	$40.64M
End Cash	$96.73M
Increase/Decrease in Cash	$56.09M
Stock-Based Compensation	$106.39M
Common Stock Dividends Paid	$-18.78M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.43
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.93
Gross Margin	51.20%
Operating Margin	13.80%
EBIT Margin	13.80%
EBITDA Margin	--
Pre-Tax Profit Margin	9.73%
Profit Margin	-7.25%
Free Cash Flow	$77.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.29
Inventory Turnover	52.33
Receiveable Turnover	0.69
Days Sales in Receivables	130.93
Return on Equity	4.79%
Return on Tangible Equity	5.24%
Return on Assets	1.92%
Return on Investments	2.62%
Book Value Per Share	$51.08
Free Cash Flow per Share	$12.91
Operating Cash Flow per Share	$13.05

Data from Zacks Investment Research, Inc.